Información del artículo
Resumen
Las filariasis son un conjunto de enfermedades infecciosas que afectan fundamentalmente al tejido linfático y la piel. Están causadas por distintas especies de nematodos y son transmitidas mediante la picadura de insectos. Están catalogadas como enfermedad desatendida, afectan a millones de personas, y producen gran invalidez y problemas sociosanitarios. Para su desarrollo suelen precisar de la permanencia en zona endémica durante largos períodos, por lo que son infrecuentemente diagnosticadas en viajeros de corta estancia. Aunque habitualmente cursan de manera asintomática, la aparición de sintomatología viene determinada, fundamentalmente, por el grado de respuesta inmune del huésped a la infección y por la carga parasitaria. El diagnóstico se basa en la demostración de las microfilarias correspondientes en muestras de sangre o de piel, aunque otros métodos pueden apoyar el diagnóstico. El tratamiento individual es efectivo, pero las medidas a nivel comunitario, sobre todo la administración de tratamiento en masa, son las más efectivas para disminuir la incidencia de las filariasis.
Palabras clave:
Filariasis
Enfermedades tropicales desatendidas
Prevención y control
Administración de tratamiento en masa
Abstract
Filariases are infections caused by distinct species of nematodes. These infections are transmitted through insect bites and primarily affect lymph nodes and skin. Filariases are classified as neglected diseases and affect millions, producing severe disability and social stigma. This type of infection is rarely diagnosed in travellers, as prolonged stays in endemic areas are usually required acquire infection. Infections may be asymptomatic, and clinical manifestations depend on the host immune response to the infection and the parasite burden. Diagnosis is based on the demonstration of microfilariae in blood or skin, but there are other methods that support the diagnosis. Individual treatment is effective, but community interventions, mostly mass drug administration, have helped to diminish the incidence of filariases.
Keywords:
Filariases
Neglected tropical diseases
Prevention and control
Mass drug administration
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.J. Hotez, D.H. Molyneux, A. Fenwick, J. Kumaresan, S.E. Sachs, J.D. Sachs, et al.
Control of neglected tropical diseases.
N Engl J Med, 357 (2007), pp. 1018-1027
[2.]
F.F. Norman, A. Pérez de Ayala, J.A. Pérez-Molina, B. Monge-Maillo, P. Zamarron, R. López-Vélez.
Neglected tropical diseases outside the tropics.
PLoS Negl Trop Dis, (2010), pp. 4e762
[3.]
L.H. Tan, M.Y. Fong, R. Mahmud, A. Muslim, Y.L. Lau, A. Kamarulzaman.
Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia.
Parasitol Int, 60 (2011), pp. 111-113
[4.]
O. Bain, D. Otranto, D.G. Diniz, J.N. Dos Santos, N.P. De Oliveira, I.N. Frota de Almeida, et al.
Human intraocular filariasis caused by Pelecitus sp. nematode, Brazil.
Emerg Infect Dis, 17 (2011), pp. 867-869
[5.]
M. Koehsler, A. Soleiman, H. Aspock, H. Auer, J. Walochnik.
Onchocerca jakutensis filariasis in humans.
Emerg Infect Dis, 13 (2007), pp. 1749-1752
[6.]
S. Uni, T. Boda, K. Daisaku, Y. Ikura, H. Maruyama, H. Hasegawa, et al.
Zoonotic filariasis caused by Onchocerca dewittei japonica in a resident of Hiroshima Prefecture, Honshu, Japan.
Parasitol Int, 59 (2010), pp. 477-480
[7.]
T.C. Orihel, M.L. Eberhard.
Zoonotic filariasis.
Clinical Microbiology Reviews, 11 (1998), pp. 366-381
[8.]
D. Otranto, N. Sakru, G. Testini, V.P. Gurlu, K. Yakar, R.P. Lia, et al.
Case report: first evidence of human zoonotic infection by Onchocerca lupi (Spirurida, Onchocercidae).
The American Journal of Tropical Medicine and Hygiene, 84 (2011), pp. 55-58
[9.]
J.A. Montoya-Alonso, I. Mellado, E. Carreton, E.D. Cabrera-Pedrero, R. Morchon, F. Simon.
Canine dirofilariosis caused by Dirofilaria immitis is a risk factor for the human population on the island of Gran Canaria, Canary Islands, Spain.
Parasitol Res, 107 (2010), pp. 1265-1269
[10.]
WHO. Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administration, 2010. Wkly Epidemiol Rep. 2011;86:377-88. Disponible en: http://www.who.int/wer
[11.]
T.B. Nutman, K.D. Miller, M. Mulligan, E.A. Ottesen.
Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations.
J Infect Dis, 154 (1986), pp. 10-18
[12.]
R.G. Van Dellen, E.A. Ottesen, T.M. Gocke, R.C. Neafie.
Loa loa. An unusual case of chronic urticaria and angioedema in the United States.
Jama, 253 (1985), pp. 1924-1925
[13.]
E.M. Lipner, M.A. Law, E. Barnett, J.S. Keystone, F. Von Sonnenburg, L. Loutan, et al.
Filariasis in travelers presenting to the GeoSentinel Surveillance Network.
PLoS Negl Trop Dis, 1 (2007), pp. e88
[14.]
A. Hoerauf, D.W. Buttner, O. Adjei, E. Pearlman.
Onchocerciasis.
BMJ, 326 (2003), pp. 207-210
[15.]
C.F. Encarnación, M.F. Giordano, H.W. Murray.
Onchocerciasis in New York City. The Moa-Manhattan connection.
Arch Intern Med, 154 (1994), pp. 1749-1751
[16.]
J.J. Padgett, K.H. Jacobsen, Loiasis:.
African eye worm.
Trans R Soc Trop Med Hyg, 102 (2008), pp. 983-989
[17.]
W.D. Melrose.
Lymphatic filariasis: new insights into an old disease.
Int J Parasitol, 32 (2002), pp. 947-960
[18.]
C.L. King.
Transmission intensity and human immune responses to lymphatic filariasis.
Parasite Immunology, 23 (2001), pp. 363-371
[19.]
T.J. Lamb, L. Le Goff, A. Kurniawan, D.B. Guiliano, K. Fenn, M.L. Blaxter, et al.
Most of the response elicited against Wolbachia surface protein in filarial nematode infection is due to the infective larval stage.
J Infect Dis, 189 (2004), pp. 120-127
[20.]
J.B. Baird, J.L. Charles, T.G. Streit, J.M. Roberts, D.G. Addiss, P.J. Lammie.
Reactivity to bacterial, fungal, and parasite antigens in patients with lymphedema and elephantiasis.
Am J Trop Med Hyg, 66 (2002), pp. 163-169
[21.]
E.A. Ottesen.
The Wellcome Trust Lecture. Infection and disease in lymphatic filariasis: an immunological perspective.
Parasitology, 104 (1992), pp. S71-S79
[22.]
C. Witt, E.A. Ottesen.
Lymphatic filariasis: an infection of childhood.
Trop Med Int Health, 6 (2001), pp. 582-606
[23.]
A. Manoharan, P.K. Das, V.B. Keerthiseelan, K.D. Ramaiah.
Trend of Wuchereria bancrofti infection in Pondicherry urban agglomeration after the withdrawal of a five year vector control programme.
J Commun Dis, 29 (1997), pp. 255-261
[24.]
W.A. Stolk, K.D. Ramaiah, G.J. Van Oortmarssen, P.K. Das, J.D. Habbema, S.J. De Vlas.
Meta-analysis of age-prevalence patterns in lymphatic filariasis: no decline in microfilaraemia prevalence in older age groups as predicted by models with acquired immunity.
Parasitology, 129 (2004), pp. 605-612
[25.]
F. Partono, P.W. Pribadi, A. Soewarta.
Epidemiological and clinical features of Brugia timori in a newly established village. Karakuak, West Flores, Indonesia.
Am J Trop Med Hyg, 27 (1978), pp. 910-915
[26.]
G. Dreyer, Z. Medeiros, M.J. Netto, N.C. Leal, L.G. De Castro, W.F. Piessens.
Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes.
Trans R Soc Trop Med Hyg, 93 (1999), pp. 413-417
[27.]
A.Y. Debrah, S. Mand, S. Specht, Y. Marfo-Debrekyei, L. Batsa, K. Pfarr, et al.
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.
PLoS Pathog, 2 (2006), pp. e92
[28.]
A.Y. Debrah, S. Mand, Y. Marfo-Debrekyei, L. Batsa, K. Pfarr, B. Lawson, et al.
Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline.
Am J Trop Med Hyg, 80 (2009), pp. 956-963
[29.]
M.J. Taylor, C. Bandi, A. Hoerauf.
Wolbachia bacterial endosymbionts of filarial nematodes.
Adv Parasitol, 60 (2005), pp. 245-284
[30.]
A. Saint Andre, N.M. Blackwell, L.R. Hall, A. Hoerauf, N.W. Brattig, L. Volkmann, et al.
The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness.
Science, 295 (2002), pp. 1892-1895
[31.]
Y.I. Coulibaly, B. Dembele, A.A. Diallo, E.M. Lipner, S.S. Doumbia, S.Y. Coulibaly, et al.
A randomized trial of doxycycline for Mansonella perstans infection.
N Engl J Med, 361 (2009), pp. 1448-1458
[32.]
M.M. Ali, O.Z. Baraka, S.I. Abdel Rahman, S.M. Sulaiman, J.F. Williams, M.M. Homeida, et al.
Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
J Infect Dis, 187 (2003), pp. 714-717
[33.]
C. Timmann, R.S. Abraha, C. Hamelmann, D.W. Buttner, B. Lepping, Y. Marfo, et al.
Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus.
Br J Dermatol, 149 (2003), pp. 782-787
[34.]
E. Pearlman.
Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): a novel role for endosymbiotic Wolbachia bacteria.
Med Microbiol Immunol, 192 (2003), pp. 57-60
[35.]
J.C. Nguyen, M.E. Murphy, T.B. Nutman, R.C. Neafie, S. Maturo, D.S. Burke, et al.
Cutaneous onchocerciasis in an American traveler.
Int J Dermatol, 44 (2005), pp. 125-128
[36.]
J.S. McCarthy, E.A. Ottesen, T.B. Nutman.
Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings.
J Infect Dis, 170 (1994), pp. 736-741
[37.]
A. Caraballo, J. Alvarado.
Report of imported cases of Loa loa in Venezuela.
Memorias do Instituto Oswaldo Cruz, 85 (1990), pp. 485
[38.]
G. Carbonez, W. Van de Sompel, T. Zeyen.
Subconjunctival Loa loa worm: case report.
Bull Soc Belge Ophtalmol, 283 (2002), pp. 45-48
[39.]
A. Bourgeade, Y. Nosny, M. Olivier-Paufique, B. Faugere.
32 cases of recurrent localized edema on return from the Tropics.
Bull Soc Pathol Exot Filiales, 82 (1989), pp. 21-28
[40.]
G. Kiefer, M. Battegay, N. Gyr, C. Hatz.
Mansonella perstans filariasis after stay in Cameroon. A 19-year-old patient born in Cameroon, in Switzerland for the last 10 years.
Praxis (Bern 1994), 91 (2002), pp. 61-66
[41.]
T.B. Nutman, J. Kazura.
Filariasis.
2nd ed, pp. 1152
[42.]
D.N. Udall.
Recent updates on onchocerciasis: diagnosis and treatment.
Clin Infect Dis, 44 (2007), pp. 53-60
[43.]
M.D. Libman, J.D. MacLean, T.W. Gyorkos.
Screening for schistosomiasis, filariasis and strongyloidiasis among expatriates returning from the tropics.
Clin Infect Dis, 17 (1993), pp. 353-359
[44.]
G.J. Weil, P.J. Lammie, N. Weiss.
The ICT Filariasis Test: a rapid-format antigen test for diagnosis of bancroftian filariasis.
Parasitol Today, 13 (1997), pp. 401-404
[45.]
C. Braga, M.I. Dourado, R.A. Ximenes, L. Alves, F. Brayner, A. Rocha, et al.
Field evaluation of the whole blood immunochromatographic test for rapid bancroftian filariasis diagnosis in the northeast of Brazil.
Rev Inst Med Trop Sao Paulo, 45 (2003), pp. 125-129
[46.]
L.S. Ayong, C.B. Tume, F.E. Wembe, G. Simo, T. Asonganyi, G. Lando, et al.
Development and evaluation of an antigen detection dipstick assay for the diagnosis of human onchocerciasis.
Trop Med Int Health, 10 (2005), pp. 228-233
[47.]
W.G. Jaoko.
Loa loa antigen detection by ELISA: a new approach to diagnosis.
East Afr Med J, 72 (1995), pp. 176-179
[48.]
G.E. Kwan-Lim, K.P. Forsyth, R.M. Maizels.
Filarial-specific IgG4 response correlates with active Wuchereria bancrofti infection.
J Immunol, 145 (1990), pp. 4298-4305
[49.]
L.J. Pérez-Arellano, C. Carranza-Rodríguez, C. Vieira-Lista, A. Muro.
Nematodosis I: filariosis.
Medicine, 10 (2010), pp. 3729-3738
[50.]
M.A. Rodríguez-Pérez, A. Domínguez-Vázquez, J. Méndez-Galván, A.M. Sifuentes-Rincón, P. Larralde-Corona, H.A. Barrera-Saldana, et al.
Antibody detection tests for Onchocerca volvulus: comparison of the sensitivity of a cocktail of recombinant antigens used in the indirect enzyme-linked immunosorbent assay with a rapidformat antibody card test.
Trans R Soc Trop Med Hyg, 97 (2003), pp. 539-541
[51.]
J.P. Akue, M. Hommel, E. Devaney.
IgG subclass recognition of Loa loa antigens and their correlation with clinical status in individuals from Gabon.
Parasite immunology, 8 (1998), pp. 387-393
[52.]
T.G. Egwang, A. Dupont, A. Leclerc, J.P. Akue, M. Pinder.
Differential recognition of Loa loa antigens by sera of human subjects from a loiasis endemic zone.
Am J Trop Med Hyg, 41 (1989), pp. 664-673
[53.]
P.D. Burbelo, R. Ramanathan, A.D. Klion, M.J. Iadarola, T.B. Nutman.
Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection.
J Clin Microbiol, 46 (2008), pp. 2298-2304
[54.]
D.L. Fink, G.A. Fahle, S. Fischer, D.F. Fedorko, T.B. Nutman.
Toward molecular parasitologic diagnosis: enhanced diagnostic sensitivity for filarial infections in mobile populations.
J Clin Microbiol, 49 (2011), pp. 42-47
[55.]
T.H. Tang, R. López-Vélez, M. Lanza, A.J. Shelley, J.M. Rubio, S.L. Luz.
Nested PCR to detect and distinguish the sympatric filarial species Onchocerca volvulus, Mansonella ozzardi and Mansonella perstans in the Amazon Region.
Memorias do Instituto Oswaldo Cruz, 105 (2010), pp. 823-828
[56.]
P. Stingl, M. Ross, D.W. Gibson, J. Ribas, D.H. Connor.
A diagnostic “patch test” for onchocerciasis using topical diethylcarbamazine.
Trans R Soc Trop Med Hyg, 78 (1984), pp. 254-258
[57.]
G. Ozoh, M. Boussinesq, A.C. Bissek, L. Kobangue, M. Kombila, J.R. Mbina, et al.
Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa.
Trop Med Int Health, 12 (2007), pp. 123-129
[58.]
M.J. Taylor, W.H. Makunde, H.F. McGarry, J.D. Turner, S. Mand, A. Hoerauf.
Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.
Lancet, 365 (2005), pp. 2116-2121
[59.]
A.Y. Debrah, S. Mand, Y. Marfo-Debrekyei, J. Larbi, O. Adjei, A. Hoerauf.
Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin.
Filaria Journal, 5 (2006), pp. 1
[60.]
Drugs for Parasitic Infections. Treatment Guidelines from The Medical Letter. 2007;5 Suppl. Disponible en: www.medicalletter.org
[61.]
J.A. Pérez-Molina, M. Díaz-Menéndez, A. Pérez-Ayala, F. Ferrere, B. Monje, F. Norman, et al.
Treatment of diseases caused by parasites.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 44-59
[62.]
R.M. Ramzy, M. El-Setouhy, H. Helmy, A.M. Kandil, E.S. Ahmed, H.A. Farid, et al.
The impact of single-dose diethylcarbamazine treatment of bancroftian filariasis in a low-endemicity setting in Egypt.
Am J Trop Med Hyg, 67 (2002), pp. 196-200
[63.]
S. Pani, G. Subramanyam Reddy, L. Das, P. Vanamail, S. Hoti, J. Ramesh, et al.
Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or coadministration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospitalbased study.
Filaria journal, 1 (2002), pp. 1
[64.]
D. Addiss, J. Critchley, H. Ejere, P. Garner, H. Gelband, C. Gamble.
Albendazole for lymphatic filariasis.
Cochrane database of systematic reviews (Online), (2004),
[65.]
A.K. Boggild, J.S. Keystone, K.C. Kain.
Tropical pulmonary eosinophilia: a case series in a setting of nonendemicity.
Clin Infect Dis, 39 (2004), pp. 1123-1128
[66.]
A. Hoerauf.
Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.
Curr Opin Infect Dis, 21 (2008), pp. 673-681
[67.]
Study evaluatting orally administered moxidectin in subjects with Onchocerca volvulus infection [consultado 5-2011]. Disponible en: http://clinicaltrials.gov/ct2/show/NCT00300768
[68.]
A.D. Klion, J. Horton, T.B. Nutman.
Albendazole therapy for loiasis refractory to diethylcarbamazine treatment.
Clin Infect Dis, 29 (1999), pp. 680-682
[69.]
T.E. Tabi, R. Befidi-Mengue, T.B. Nutman, J. Horton, A. Folefack, E. Pensia, et al.
Human loiasis in a Cameroonian village: a double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen.
Am J Trop Med Hyg, 71 (2004), pp. 211-215
[70.]
M. Kombila, T.H. Duong, A. Ferrer, J.L. Perret, M.C. Marion, C. Nguiri, et al.
Short- and long-term action of multiple doses of ivermectin on loiasis microfilaremia.
Am J Trop Med Hyg, 58 (1998), pp. 458-460
[71.]
A.D. Klion, A. Massougbodji, J. Horton, S. Ekoue, T. Lanmasso, N.L. Ahouissou, et al.
Albendazole in human loiasis: results of a double-blind, placebo-controlled trial.
J Infect Dis, 168 (1993), pp. 202-206
[73.]
A.A. González, D.D. Chadee, S.C. Rawlins.
Ivermectin treatment of mansonellosis in Trinidad.
West Indian Med J, 48 (1999), pp. 231-234
[74.]
E.A. Ottesen, P.J. Hooper, M. Bradley, G. Biswas.
The global programme to eliminate lymphatic filariasis: health impact after 8 years.
PLoS Negl Trop Dis, 2 (2008), pp. e317
[75.]
D. Kyelem, G. Biswas, M.J. Bockarie, M.H. Bradley, M. El-Setouhy, P.U. Fischer, et al.
Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs.
The American Journal of Tropical Medicine and Hygiene, 79 (2008), pp. 480-484
[76.]
M.Y. Osei-Atweneboana, J.K. Eng, D.A. Boakye, J.O. Gyapong, R.K. Prichard.
Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Lancet, 369 (2007), pp. 2021-2029
[77.]
M.J. Bockarie, E.M. Pedersen, G.B. White, E. Michael.
Role of vector control in the global program to eliminate lymphatic filariasis.
Annu Rev Entomol, 54 (2009), pp. 469-487
[78.]
J.D. Turner, N. Tendongfor, M. Esum, K.L. Johnston, R.S. Langley, L. Ford, et al.
Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
PLoS Negl Trop Dis, 4 (2010), pp. e660
[79.]
W.A. Stolk, S.J. De Vlas, J.D. Habbema.
Anti-Wolbachia treatment for lymphatic filariasis.
Lancet, 365 (2005), pp. 2067-2068
[80.]
M.J. Taylor, A. Hoerauf, M. Bockarie.
Lymphatic filariasis and onchocerciasis.
Lancet, 376 (2010), pp. 1175-1185
[81.]
B.L. Makepeace, S.A. Jensen, S.J. Laney, C.K. Nfon, L.M. Njongmeta, V.N. Tanya, et al.
Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.
PLoS Negl Trop Dis., 3 (2009), pp. e544
[82.]
J. Madhumathi, P.R. Prince, G. Anugraha, P. Kiran, D.N. Rao, M.V. Reddy, et al.
Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis.
Vaccine, 28 (2010), pp. 5038-5048
Copyright © 2011. Elsevier España S.L.. Todos los derechos reservados
